TC BioPharm Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:TC BioPharm Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10954
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥101,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
TC BioPharm Ltd (TC BioPharm) is an immunotherapy company that develops cell based products for treatment of cancer and viral infection. The company pipeline products are intended for the treatment of ovarian cancer, breast cancer and epidermolysisbullosa related disease, among others. It works in collaboration with various cancer centers in Glasgow, Edinburgh and Southampton; in the UK to develop ImmuniCell, among others. TC BioPharm provides clinical manufacturing facility which is located in Holytown, Scotland, the UK. The company operates in the UK. TC BioPharm is headquartered in Edinburgh, the UK.

TC BioPharm Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
TC BioPharm Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
TC BioPharm Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
TC BioPharm Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
TC BioPharm Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
TC BioPharm Ltd, Medical Devices Deals, 2012 to YTD 2018 9
TC BioPharm Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
TC BioPharm Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
TC BioPharm Raises More Than USD7.8 Million in Series A Financing Round 11
TC BioPharm Raises USD1.1 million in Venture Financing 12
TC BioPharm Raises USD0.4 Million Through Seed Funding 13
TC BioPharm Raises USD2 Million in Venture Financing 14
Partnerships 15
TC BioPharm and Scotia Biologics Enter into Agreement 15
TC Biopharm and Nipro Enter into Co-Development Partnership 16
TC BioPharm Enters into Co-Development Agreement with Sistemic 17
Licensing Agreements 18
bluebird bio Enters into Licensing Agreement with TC BioPharm 18
TC BioPharm Enters into Licensing Agreement with University College London 19
TC BioPharm Enters into Licensing Agreement with Medinet 20
TC BioPharm Ltd – Key Competitors 21
TC BioPharm Ltd – Key Employees 22
TC BioPharm Ltd – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 24
Strategy And Business Planning 24
Feb 14, 2018: Scottish Immunotherapy Company TC Biopharm Opens First Overseas Office in Japan 24
Product News 25
08/02/2017: TCB Selected For EU Horizon 2020 Funding to Progress Novel, Mass-Market Cell Therapies to Clinical Trial 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
TC BioPharm Ltd, Pharmaceuticals & Healthcare, Key Facts 2
TC BioPharm Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
TC BioPharm Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
TC BioPharm Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
TC BioPharm Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
TC BioPharm Ltd, Medical Devices Deals, 2012 to YTD 2018 9
TC BioPharm Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
TC BioPharm Raises More Than USD7.8 Million in Series A Financing Round 11
TC BioPharm Raises USD1.1 million in Venture Financing 12
TC BioPharm Raises USD0.4 Million Through Seed Funding 13
TC BioPharm Raises USD2 Million in Venture Financing 14
TC BioPharm and Scotia Biologics Enter into Agreement 15
TC Biopharm and Nipro Enter into Co-Development Partnership 16
TC BioPharm Enters into Co-Development Agreement with Sistemic 17
bluebird bio Enters into Licensing Agreement with TC BioPharm 18
TC BioPharm Enters into Licensing Agreement with University College London 19
TC BioPharm Enters into Licensing Agreement with Medinet 20
TC BioPharm Ltd, Key Competitors 21
TC BioPharm Ltd, Key Employees 22
TC BioPharm Ltd, Other Locations 23

List of Figures
TC BioPharm Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
TC BioPharm Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
TC BioPharm Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
TC BioPharm Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
TC BioPharm Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
TC BioPharm Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
TC BioPharm Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
TC BioPharm Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
TC BioPharm Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[TC BioPharm Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Discovery Inc (DISCA):企業の財務・戦略的SWOT分析
    Discovery Inc (DISCA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Yamazaki Baking Co., Ltd.:戦略・SWOT・企業財務分析
    Yamazaki Baking Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Yamazaki Baking Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Progressive Building Society:企業の戦略・SWOT・財務情報
    Progressive Building Society - Strategy, SWOT and Corporate Finance Report Summary Progressive Building Society - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • NeoDynamics AB:企業の製品パイプライン分析
    Summary NeoDynamics AB (NeoDynamics) is a medical technology company that develops medical solutions for the early detection and treatment of cancer. The company develops the NeoNavia biopsy system that helps to collect samples from breast lesions or axillary lymph nodes for diagnostic analysis of b …
  • KAMCO Investment Company K.S.C.P. (KAMCO):企業の財務・戦略的SWOT分析
    KAMCO Investment Company K.S.C.P. (KAMCO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Specsavers Optical Group Ltd:企業の戦略・SWOT・財務分析
    Specsavers Optical Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Specsavers Optical Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Orpea SA (ORP):企業の財務・戦略的SWOT分析
    Summary Orpea SA (Orpea) is a healthcare consulting company that offers clinical care services. The company provides services such as suite care clinic services, retirement homes, and mental hospital services, among others. Its mental hospital services include treatment of mood disorders, overuse sy …
  • Superdry Plc:企業の戦略・SWOT・財務分析
    Superdry Plc - Strategy, SWOT and Corporate Finance Report Summary Superdry Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • vTv Therapeutics Inc (VTVT):企業の財務・戦略的SWOT分析
    Summary vTv Therapeutics Inc (vTv), formerly TransTech Inc, is a pharmaceutical company that discovers, develops and commercializes human therapeutics. The company’s pipeline product portfolio includes small molecule clinical and pre-clinical drug candidates for the treatment of a wide range of huma …
  • PACCAR Inc.:企業の戦略・SWOT・財務情報
    PACCAR Inc. - Strategy, SWOT and Corporate Finance Report Summary PACCAR Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Space Exploration Technologies Corp:企業の戦略・SWOT・財務情報
    Space Exploration Technologies Corp - Strategy, SWOT and Corporate Finance Report Summary Space Exploration Technologies Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Secom Co Ltd (9735):企業の財務・戦略的SWOT分析
    Secom Co Ltd (9735) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Toppan Printing Co Ltd:企業のM&A・事業提携・投資動向
    Toppan Printing Co Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Toppan Printing Co Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Osmotica Pharmaceutical Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Osmotica Pharmaceutical Corp (Osmotica) is a pharmaceutical company that specializes in drug delivery technologies and neurology based therapies. The company provides product portfolio such as nifedipine, oxybutynin, venlafaxine and desvenlafaxine, among others. It offers capabilities such a …
  • BrainScope Company Inc:医療機器:M&Aディール及び事業提携情報
    Summary BrainScope Company Inc (BrainScope) is a medical device company that offers medical neurotechnology products. The company develops and distributes non-invasive instruments for the treatment of traumatic brain injuries, moderate traumatic brain injury and mild traumatic brain injury. It provi …
  • Juniper Pharmaceuticals Inc (JNP):製薬・医療:M&Aディール及び事業提携情報
    Summary Juniper Pharmaceuticals Inc (Juniper), formerly Columbia Laboratories Inc is a women’s health therapeutic company that focuses on developing therapeutics that address unmet medical needs. It develops, manufactures, licenses and sells pharmaceutical products in women's health. The company uti …
  • ITV plc:企業の戦略・SWOT・財務分析
    ITV plc - Strategy, SWOT and Corporate Finance Report Summary ITV plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Inretail Peru Corp. (INRETC1):企業の財務・戦略的SWOT分析
    Inretail Peru Corp. (INRETC1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • C&A:企業の戦略・SWOT・財務情報
    C&A - Strategy, SWOT and Corporate Finance Report Summary C&A - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing …
  • Foxconn Technology Co Ltd:企業の戦略・SWOT・財務分析
    Foxconn Technology Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Foxconn Technology Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆